Science, medicine, and the future: Therapeutic angiogenesis
- 5 June 1999
- Vol. 318 (7197) , 1536-1539
- https://doi.org/10.1136/bmj.318.7197.1536
Abstract
Editorial by Brindle et al Therapeutic angiogenesis is the clinical use of growth factors to enhance or promote the development of collateral blood vessels in ischaemic tissue. Progress in understanding the process of angiogenesis, the isolation of angiogenic growth factors, successful preclinical studies, and promising early results in clinical trials have created great excitement about the potential of therapeutic angiogenesis.1 Although many questions remain, therapeutic angiogenesis may be the next major advance in the treatment of ischaemic heart disease. Ischaemic heart disease caused 6.3 million deaths worldwide in 1990, and it remains the leading cause of morbidity and mortality in the world.2 Advances in secondary prevention, reperfusion treatment for acute myocardial infarction, and revascularisation via coronary artery bypass graft surgery and percutaneous coronary interventions have improved long term survival of patients with established coronary heart disease. With these improvements in survival, and the ageing of populations, increasing numbers of patients are left with substantial myocardial ischaemia that is not amenable to revascularisation. Despite major advances in revascularisation techniques, these patients may constitute 5-15% of patients undergoing coronary angiography. The importance of the coronary collateral circulation has become increasingly clear over the past 20 years.3–5 The coronary collateral circulation is a complex network of interconnecting vessels, most of which are <200 μm in diameter. Highly variable from patient to patient, this network develops from the recruitment of existing blood vessels as well as the creation of new vessels. The main stimulants for collateral growth are duration and severity of ischaemia, shear stress on the arterial wall, and inflammation.5 In acute myocardial infarction the presence of collateral circulation decreases infarct size, improves left ventricular function, decreases the likelihood of an aneurysm forming, and improves survival. 3 4 While collateral circulation may provide adequate coronary perfusion at …Keywords
This publication has 16 references indexed in Scilit:
- Induction of Neoangiogenesis in Ischemic Myocardium by Human Growth FactorsCirculation, 1998
- Angiogenesis: a dynamic balance of stimulators and inhibitors.1997
- Mortality by cause for eight regions of the world: Global Burden of Disease StudyPublished by Elsevier ,1997
- Mechanisms of angiogenesisNature, 1997
- Angiogenesis in ischemic heart diseaseNature Medicine, 1997
- Molecular Mechanisms of Coronary Collateral Vessel GrowthCirculation Research, 1996
- Clinical Applications of Research on AngiogenesisNew England Journal of Medicine, 1995
- Three-year sustained benefit from enhanced external counterpulsation in chronic angina pectorisThe American Journal of Cardiology, 1995
- The role of the coronary collateral circulation in limiting myocardial ischemia and infarct sizeAmerican Heart Journal, 1993
- Recent insights into coronary collateral circulation.Circulation, 1992